These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2912022)

  • 1. A phase II trial of intermittent leukocyte interferon and high dose chlorambucil in the treatment of non-Hodgkin's lymphoma resistant to conventional therapy.
    Clark RH; Dimitrov NV; Axelson JA; Charamella LJ; Stott PB
    Am J Clin Oncol; 1989 Feb; 12(1):75-7. PubMed ID: 2912022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte interferon as a possible biological response modifier in lymphoproliferative disorders resistant to standard therapy.
    Clark RH; Dimitrov NV; Axelson JA; Charamella LJ
    J Biol Response Mod; 1984 Dec; 3(6):613-9. PubMed ID: 6512561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma.
    Chisesi T; Capnist G; Vespignani M; Dini E
    Cancer Treat Rev; 1988 Jan; 15 Suppl A():27-33. PubMed ID: 2963691
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose chlorambucil and dexamethasone for relapsed non-Hodgkin's lymphomas.
    Joseph G; Hadley T; Djulbegovic B; Hamm J; Seeger J; Blumenreich M; Woodcock T
    Am J Clin Oncol; 1993 Aug; 16(4):319-22. PubMed ID: 8328409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of interferon alpha-2, chlorambucil and prednisone in previously treated patients with low-grade non-Hodgkin's lymphomas. Results of a phase II study.
    Molica S; Tucci L; Levato D; Levato L; Manfredi L
    Tumori; 1993 Jun; 79(3):195-7. PubMed ID: 8236503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin's lymphoma.
    Martinelli G; Laszlo D; Bertolini F; Pastano R; Mancuso P; Calleri A; Vanazzi A; Santoro P; Cavalli F; Zucca E
    Br J Haematol; 2003 Oct; 123(2):271-7. PubMed ID: 14531908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma.
    Chisesi T; Capnist G; Vespignani M; Cetto G
    Invest New Drugs; 1987; 5 Suppl():S35-40. PubMed ID: 3298132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of low-grade non-Hodgkin's lymphoma by cytoreductive chemotherapy with prednimustine/mitoxantrone followed by interferon alpha-2b maintenance: results of a clinical phase II study.
    Hiddemann W; Unterhalt M; Koch P; Nahler M; van de Loo J
    Semin Oncol; 1990 Dec; 17(6 Suppl 10):20-3. PubMed ID: 2259919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory low grade lymphoma with chlorambucil alternating with interferon and radiotherapy.
    Avilés A; Talavera A; Guzmán R; Cuadra I
    Cancer Biother; 1995; 10(4):273-7. PubMed ID: 8590892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy with alpha-interferon in non-Hodgkin's lymphoma with a low grade of malignancy (correct title supplied from Table of Contents)].
    Chisesi T
    Haematologica; 1990; 75 Suppl 4():72-7. PubMed ID: 2074057
    [No Abstract]   [Full Text] [Related]  

  • 11. Chlorambucil and interferon for low grade non-Hodgkin's lymphoma.
    Rohatiner AZ; Richards MA; Barnett MJ; Stansfeld AG; Lister TA
    Br J Cancer; 1987 Feb; 55(2):225-6. PubMed ID: 3814493
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials of alpha-interferon in the treatment of non-Hodgkin's lymphoma.
    Gaynor ER; Fisher RI
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):12-7. PubMed ID: 1948124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma.
    Morris GJ; Millenson MM; Padavic-Shaller K; Wang H; Rogatko A; Clyde J; Boyd RL; Yeslow G; Halbherr T; Schilder RJ; Smith MR
    Haematologica; 2004 Dec; 89(12):1484-91. PubMed ID: 15590399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
    Hagenbeek A; Carde P; Meerwaldt JH; Somers R; Thomas J; De Bock R; Raemaekers JM; van Hoof A; De Wolf-Peeters C; van Glabbeke M
    J Clin Oncol; 1998 Jan; 16(1):41-7. PubMed ID: 9440721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary treatment of low-grade non-Hodgkin's lymphoma using an all oral anthracycline-containing regimen, chlorambucil, idarubicin, dexamethasone (CID)--a phase II study.
    Taylor PR; Jackson GH; Galloway MJ; Soukop M; Tinegate H; Angus B; Proctor SJ
    Cancer Chemother Pharmacol; 2000; 46(1):63-8. PubMed ID: 10912580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNU.
    Lennard AL; Carey PJ; Jackson GH; Proctor SJ
    Cancer Chemother Pharmacol; 1990; 26(4):301-5. PubMed ID: 2369796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin's lymphoma. A four-drug regimen suitable for elderly patients with advanced disease.
    Watkin SW; Green JA
    Acta Oncol; 1990; 29(6):733-7. PubMed ID: 2223144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha Interferon maintenance therapy in patients with low-grade non-Hodgkin's lymphomas after cytoreductive chemotherapy with prednimustine and mitoxantrone.
    Hiddemann W; Unterhalt M; Koch P; Nahler M; Herrmann R; van de Loo J
    Eur J Cancer; 1991; 27 Suppl 4():S37-9. PubMed ID: 1799474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.
    Smalley RV; Andersen JW; Hawkins MJ; Bhide V; O'Connell MJ; Oken MM; Borden EC
    N Engl J Med; 1992 Nov; 327(19):1336-41. PubMed ID: 1406835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent combination chemotherapy with chlorambucil and prednisone of low-grade malignant non-Hodgkin's lymphomas according to the Kiel classification.
    Stolzenbach G; Garbrecht M
    J Cancer Res Clin Oncol; 1979 Feb; 93(2):189-94. PubMed ID: 438282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.